Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Corbus Pharmaceuticals Holdings, Inc. | Director | Common Stock, par value $0.0001 per share | 5.57K | $167K | $30.00 | Aug 16, 2024 | Direct |
Janux Therapeutics, Inc. | Director | Common Stock | 2.5K | $137K | $54.75 | Jun 26, 2024 | Direct |
PMV Pharmaceuticals, Inc. | COO, CFO | Employee Stock Option (right to buy) | 150K | May 12, 2023 | Direct | ||
Janux Therapeutics, Inc. | Director | Stock Option (right to buy) | 8.35K | Jun 26, 2024 | Direct | ||
Corbus Pharmaceuticals Holdings, Inc. | Director | Stock options (right to buy) | 5.57K | Aug 16, 2024 | Direct |